Mastodawn

A Multiregional Decentralized #ClinicalTrial Program to Improve Access

"...decentralized capabilities may be associated with enhanced participant #access and #representation in clinical trials..."

#Research #Evidence #Vulnerability #Frailty #Science #RCT #ScienceMastodon

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2849940?utm_source=bluesky&utm_medium=social_jamajno&utm_term=20720066374&utm_campaign=article_alert&linkId=955343305

Global News National Jun 3

Pancreatic cancer pill that doubled survival may get Canada clinical trial
Medical oncologist Dr. Jennifer Knox independently reviewed a U.S.-led study of the experimental drug daraxonrasib and calls the results "amazing."
#Canada #Health #PancreaticCancer #PrincessMargaretCancerCentre
https://globalnews.ca/news/11888568/pancreatic-cancer-pill-that-doubled-survival-may-get-canadian-clinical-trial/

Global News Canada Jun 3

Pancreatic cancer pill that doubled survival may get Canada clinical trial
Medical oncologist Dr. Jennifer Knox independently reviewed a U.S.-led study of the experimental drug daraxonrasib and calls the results "amazing."
#Canada #Health #PancreaticCancer #PrincessMargaretCancerCentre
https://globalnews.ca/news/11888568/pancreatic-cancer-pill-that-doubled-survival-may-get-canadian-clinical-trial/

Global News Health Jun 3

Pancreatic cancer pill that doubled survival may get Canada clinical trial
Medical oncologist Dr. Jennifer Knox independently reviewed a U.S.-led study of the experimental drug daraxonrasib and calls the results "amazing."
#Canada #Health #PancreaticCancer #PrincessMargaretCancerCentre
https://globalnews.ca/news/11888568/pancreatic-cancer-pill-that-doubled-survival-may-get-canadian-clinical-trial/

Global News Jun 3

Pancreatic cancer pill that doubled survival may get Canada clinical trial
Medical oncologist Dr. Jennifer Knox independently reviewed a U.S.-led study of the experimental drug daraxonrasib and calls the results "amazing."
#Canada #Health #PancreaticCancer #PrincessMargaretCancerCentre
https://globalnews.ca/news/11888568/pancreatic-cancer-pill-that-doubled-survival-may-get-canadian-clinical-trial/

martincidmag Jun 2

One year of a drug delayed rheumatoid arthritis for four years in at-risk patients

https://www.martincid.com/science/abatacept-delays-rheumatoid-arthritis-four-years-2/

#ClinicalTrial #AutoimmuneDisease #RheumatoidArthritis

One year of a drug delayed rheumatoid arthritis for four years in at-risk patients

The people in this trial were not sick yet. They carried the warning signs of rheumatoid arthritis but none of the damage. One year of an immune-calming drug he

Martin Cid Magazine

Asifnawaz Jun 2

Abivax shares plunge despite positive colitis trial results reported

#Abivax #BiotechStocks #ClinicalTrial #StockMarket
https://meyka.com/blog/abivax-shares-plunge-32-despite-positive-colitis-trial-results-amid-safety-concerns-2606/

Abivax Shares Plunge 32% Despite Positive Colitis Trial Results Amid Safety Concerns | Meyka

Abivax Shares tumbled 32% despite strong Phase 3 ulcerative colitis results, as investors focused on reported cancer cases and safety concerns.

Asifnawaz Jun 1

Eli Lilly and Company Retevmo shows major reduction in cancer recurrence risk trial

#EliLilly #Retevmo #CancerResearch #ClinicalTrial
https://meyka.com/blog/eli-lilly-retevmo-cuts-cancer-recurrence-or-death-risk-by-83-in-phase-3-trial-of-151-nsclc-patients-2606/

Eli Lilly Retevmo Cuts Cancer Recurrence or Death Risk by 83% in Phase 3 Trial of 151 NSCLC Patients | Meyka

Eli Lilly's Retevmo cut cancer recurrence or death risk by 83% in the Phase 3 LIBRETTO-432 trial of 151 NSCLC patients. 24-month EFS hit 92% vs 61% on placebo. Full trial data inside.